Comparación de los beneficios del Biodentine y MTA en el tratamiento endodóntico

Abstract

Introduction: Endodontics has advanced with the use of bioceramic materials such as Mineral Trioxide Aggregate (MTA) and Biodentine, both recognized for their biocompatibility, sealing capacity, and healing properties. These materials are used in treatments such as root canal filling and pulpotomy, but they present clinical differences that warrant comparison. Objective: To compare the benefits of Biodentine and MTA in endodontic treatments, focusing on clinical efficacy, healing effectiveness, apical sealing, and biocompatibility. Methods: A systematic review was conducted following PRISMA guidelines and using the PICO strategy. Fifteen studies (clinical and in vitro trials) published between 2018 and 2025 were analyzed, extracted from databases such as PubMed, Scopus, and Web of Science. Methodological quality was assessed using the PEDro scale. Results: Both materials demonstrated high effectiveness, with over 90% clinical and radiographic success. Biodentine showed advantages over MTA in terms of biocompatibility, better marginal adaptation, less tooth discoloration, and greater capacity to induce the formation of the reparative dentin bridge. It was also easier to handle and set faster. Conclusion: While MTA remains an effective material, Biodentine proved to be a more efficient, esthetic, and favorable option in endodontic treatments, particularly in primary dentition and anterior teeth. Keywords: MTA, Biodentine, root canal filling, endodontic treatment, bioceramics.